<DOC>
	<DOCNO>NCT02286609</DOCNO>
	<brief_summary>This non-randomized , open-label , single-dose study compare PK 21-desacetyl-DFZ , data permit , deflazacort 8 subject moderate hepatic impairment ( base Child Pugh classification , Grade B ) 8 healthy match control subject ( age , body mass index [ BMI ] , gender ) .</brief_summary>
	<brief_title>A Single Dose Evaluation Effects Moderate Hepatic Impairment Deflazacort Pharmacokinetics</brief_title>
	<detailed_description>This non-randomized , open-label , single-dose study compare PK 21-desacetyl-DFZ , data permit , deflazacort 8 subject moderate hepatic impairment ( base Child Pugh classification , Grade B ) 8 healthy match control subject ( age , body mass index [ BMI ] , gender ) . On Day 1 , single oral dose deflazacort administer follow serial blood sample 24 hour assess PK 21-desacetyl-DFZ , data permit , deflazacort . Safety monitor throughout study repeat clinical laboratory evaluation . Subjects return Clinical Research Unit ( CRU ) 3 day ( ± 1 day ) follow study drug administration determine adverse event ( AEs ) occur since last study visit . Subjects terminate study early contact Principal Investigator ( PI ) deem necessary . A total sixteen ( 16 ) adult male female subject enrol . Hepatic Impaired Cohort : Eight ( 8 ) subject moderate hepatic insufficiency ( score 7 9 , Child-Pugh scale ) . Healthy Match Control Cohort : Eight ( 8 ) healthy subject . Subjects match age [ ± 15 year ] , BMI [ ± 15 % ] , gender [ 1:1 ] subject moderate hepatic impaired cohort .</detailed_description>
	<mesh_term>Liver Diseases</mesh_term>
	<mesh_term>Deflazacort</mesh_term>
	<criteria>All Subjects Continuous nonsmoker moderate smoker . For female nonchildbearing potential : must undergo one sterilization procedures postmenopausal amenorrhea least 1 year prior dose FSH serum level consistent postmenopausal status A non vasectomize , male subject must agree use condom spermicide abstain sexual intercourse study 90 day If male , must agree donate sperm dose 90 day Subject Moderate Hepatic Impairment Adult male female , 18 80 year age BMI ≥ 18.5 ≤ 40.0 kg/m2 Subject 's score ChildPugh scale must range 7 9 ( moderate hepatic insufficiency ) Subject diagnosis chronic ( &gt; 6 month ) , stable ( acute episode illness within previous 2 month due deterioration hepatic function ) hepatic insufficiency feature cirrhosis due etiology . Healthy Subject Healthy adult male female subject match 1:1 specific subject moderate hepatic impairment cohort base upon age , BMI , gender . Subject mentally legally incapacitated significant emotional problem time screen visit expect conduct study . History presence hypersensitivity idiosyncratic reaction study drug , relate compound ( e.g. , steroid formulation include lactose corn starch ) . History ( within last year prior dose ) presence peptic ulcer . History presence : Gastritis esophagitis , diverticulitis , ulcerative colitis ( probability impend perforation ) , abscess pyogenic infection , fresh intestinal anastomosis ; Previous corticoidsinduced myopathy ; Ocular herpes simplex ; Symptomatic cardiomyopathy screening ; Immunosuppression contraindication corticosteroid treatment ; History chronic systemic fungal viral infection ; Galactose intolerance , Lapp lactose deficiency , glucosegalactose malabsorption ; Osteoporosis ; Myasthenia gravis ; Epilepsy ; Idiopathic hypocalcuria . Seated blood pressure le 90/40 mmHg great 160/95 mmHg Seated heart rate lower 40 bpm high 99 bpm QTcF interval &gt; 500 msec Has receive live liveattenuated vaccine within 30 day Has receive immunosuppressive agent , coal tar , and/or radiation therapy within 30 day Has receive injectable corticoid 12 week prior dose oral form corticoid 30 day Unable refrain anticipates use : Any drug know moderate strong inhibitor inducer cytochrome P450 ( CYP ) 3A Pglycoprotein ( Pgp ) 14 day 28 day , respectively Any medication substance , vitamin supplement , natural herbal supplement discontinue least 14 day Female subject childbearing potential . Female subject pregnant lactating . Positive result screen HIV . Has diet incompatible study diet within 28 day Donation blood significant blood loss within 56 day Plasma donation within 7 day Participation another clinical trial within 28 day Subject Moderate Hepatic Impairment Has history organ transplant . History drug abuse within past 2 year Has positive urine drug urine/breath alcohol test Healthy Subject History presence alcoholism drug abuse within past 2 year Positive urine drug urine/breath alcohol test result screen check . Positive result screen HBsAg HCV .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>